Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.54 |
| ▸ | PKM | P14618 | 4/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | TP53 | P04637 | 3/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | STAT6 | P42226 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | CASP1 | P29466 | 1/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.54 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.54 |
| ▸ | RELA | Q04206 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | THPO | P40225 | 1/20 | 0.54 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethylaminoparthenolide SCHEMBL29496871 | 1.00 | NLRP3 (0.54) | NLRP3ALDH1A1PKMLMNATP53 | |
| Dimethylaminoparthenolide SCHEMBL6741653 | 1.00 | NLRP3 (0.54) | NLRP3ALDH1A1PKMLMNATP53 | |
| Dimethylaminoparthenolide SCHEMBL16419384 | 1.00 | NLRP3 (0.54) | NLRP3ALDH1A1PKMLMNATP53 | |
| Dimethylaminoparthenolide SCHEMBL16414642 | 1.00 | NLRP3 (0.54) | NLRP3ALDH1A1PKMLMNATP53 | |
| Dimethylaminoparthenolide SCHEMBL16414703 | 1.00 | NLRP3 (0.54) | NLRP3ALDH1A1PKMLMNATP53 | |
| Dimethylaminoparthenolide SCHEMBL10099623 | 1.00 | NLRP3 (0.54) | NLRP3ALDH1A1PKMLMNATP53 | |
| Dimethylaminoparthenolide SCHEMBL6741648 | 1.00 | NLRP3 (0.54) | NLRP3ALDH1A1PKMLMNATP53 | |
| SCHEMBL16419390 | 0.93 | NLRP3 (0.52) | NLRP3ALDH1A1PKMLMNATP53 | |
| SCHEMBL15336432 | 0.93 | NLRP3 (0.52) | NLRP3ALDH1A1PKMLMNATP53 | |
| SCHEMBL16419389 | 0.91 | NLRP3 (0.52) | NLRP3ALDH1A1PKMLMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230210813-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2023-07-06 | — | — | US | disclosed |
| US-20230210813-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230210813-A1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE | CMA1, IAPP, DHPS | NLRP3 935/4885ALDH1A1 1573/4885PKM 140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.